HARNESSING THE POWER OF IN VIVO PROTEIN PRODUCTION

INOVIO is a clinical-stage biotechnology company focused on developing DNA medicines to fight HPV-related diseases, cancer and infectious diseases. We use proprietary technology to design DNA plasmids —small circular DNA molecules that work like software that the body’s cells can download to learn how to produce specific proteins to target and fight disease. Our proprietary investigational CELLECTRA® delivery devices have been designed to optimally deliver our DNA medicines into the body’s cells, without the use of chemical adjuvants, lipid nanoparticles or viral vectors.

Latest Inovio News